These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 13663035)

  • 1. Chromatographic studies of purine metabolism. IV. Reversal of azaserine-induced inhibition by phenylalanine and tryptophan.
    TOMISEK AJ; REID MR; SKIPPER HE
    Cancer Res; 1959 Jun; 19(5):489-93. PubMed ID: 13663035
    [No Abstract]   [Full Text] [Related]  

  • 2. Purine metabolism in bacteria. IV. L-azaserine as an inhibitor.
    GOLLUB EG; GOTS JS
    J Bacteriol; 1956 Dec; 72(6):858-64. PubMed ID: 13398378
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.
    TARNOWSKI GS; STOCK CC
    Cancer Res; 1957 Nov; 17(10):1033-9. PubMed ID: 13489704
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzymatic degradation of azaserine.
    JACQUEZ JA; SHERMAN JH
    Cancer Res; 1962 Jan; 22():56-61. PubMed ID: 14450824
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on the action of azaserine in mammalian tissues.
    HENDERSON JF; LEPAGE GA; MCIVER FA
    Cancer Res; 1957 Jul; 17(6):609-12. PubMed ID: 13446847
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo sensitivity of normal and neoplastic mouse tissues to azaserine.
    MOORE EC; LEPAGE GA
    Cancer Res; 1957 Sep; 17(8):804-8. PubMed ID: 13460988
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S
    Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes.
    PINE EK
    J Natl Cancer Inst; 1958 Nov; 21(5):973-84. PubMed ID: 13599021
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors.
    KELLY HJ; SKIPPER HE; TOMISEK AJ
    Arch Biochem Biophys; 1956 Oct; 64(2):437-55. PubMed ID: 13363451
    [No Abstract]   [Full Text] [Related]  

  • 10. Azaserine: pathological and pharmacological studies.
    STERNBERG SS; PHILIPS FS
    Cancer; 1957; 10(5):889-901. PubMed ID: 13472634
    [No Abstract]   [Full Text] [Related]  

  • 11. Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor.
    ANDERSON EP; JACQUEZ JA
    Cancer Res; 1962 Jan; 22():27-37. PubMed ID: 13861221
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of action of azaserine on Gaffkya homari.
    AARONSON S
    J Bacteriol; 1959 May; 77(5):548-51. PubMed ID: 13654215
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine.
    SARTORELLI AC; LEPAGE GA
    Cancer Res; 1958 Sep; 18(8 Part 1):938-42. PubMed ID: 13573368
    [No Abstract]   [Full Text] [Related]  

  • 14. The LIV-I/LS system as a determinant of azaserine sensitivity of Escherichia coli K-12.
    Koyanagi T; Katayama T; Suzuki H; Kumagai H
    FEMS Microbiol Lett; 2004 Aug; 237(1):73-7. PubMed ID: 15268940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
    HENDERSON JF; JUNGA IG
    Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of root growth by azaserine.
    NORMAN AG
    Science; 1955 Feb; 121(3137):213-4. PubMed ID: 13237973
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic studies of azaserine.
    EHRLICH J; ANDERSON LE; COFFEY GL; HILLEGAS AB; KNUDSEN MP; KOEPSELL HJ; KOHBERGER DL; OYAAS JE
    Nature; 1954 Jan; 173(4393):72. PubMed ID: 13132876
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease.
    ELLISON RR; KARNOFSKY DA; STERNBERG SS; MURPHY ML; BURCHENAL JH
    Cancer; 1954 Jul; 7(4):801-14. PubMed ID: 13172694
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of o-diazoacetyl-L-serine (azaserine) on the pregnancy of the dog; a preliminary report.
    FRIEDMAN MH
    J Am Vet Med Assoc; 1957 Feb; 130(4):159-62. PubMed ID: 13416078
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide.
    POTTER M; LAW LW
    J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.